ArticleCureus2023

The Lack of a Durable Response to Tofacitinib in Anti-PL-12 Anti-synthetase Syndrome With Progressive Interstitial Pneumonitis.

Muaamar B Baldawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.